Makers Laboratories Ltd

As of June 30, 2026, Makers Laboratories Ltd carries a market capitalization of 860.57M, placing it among publicly traded companies globally. Its enterprise value stands at 860.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Makers Laboratories Ltd has 5.90M shares outstanding.

As of June 30, 2026, Makers Laboratories Ltd trades at a trailing price-to-earnings ratio of 25.10.

As of June 30, 2026, Makers Laboratories Ltd trades at an EV/EBITDA multiple of 4.60 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.58 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.08 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 860.57M versus a market cap of 860.57M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 12.11M in revenue per employee across its workforce of 122.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Makers Laboratories Ltd recorded 42.97M in income tax expense. That works out to an effective tax rate of 27.78, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 154.68M, leaving 34.19M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Makers Laboratories Ltd's stock has gained approximately 42.22% over the past 52 weeks. The 50-day moving average sits at 186.01, while the 200-day moving average is 155.94.

Over the twelve months ended June 30, 2026, Makers Laboratories Ltd generated 1.48B in revenue and converted that into 34.19M in net income, yielding earnings per share of 18.99. EBITDA reached 186.89M, while operating income came in at 141.54M.

Over the twelve months ended June 30, 2026, Makers Laboratories Ltd posted a gross margin of 54.92, reflecting its pricing power and cost economics. The operating margin of 9.54 and net profit margin of 2.30 provide insight into operational efficiency.

Makers Laboratories Ltd's most recent stock split took place on March 30, 2022 with a 71:74 split ratio.